Clinical Trials in New York

Showing 6041-6060 of 17,259 trials

Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy

NCT02742090

The main objective of this study is to determine the progression free survival of umbralisib in participants who were intolerant to prior BTK (Bruton Tyrosine Kinase) inhibitors (ibrutinib, ACP-196, other) or prior PI3K-delta inhibitors (idelalisib, duvelisib, other).

Chronic Lymphocytic Leukemia

TG Therapeutics, Inc.51 participantsStarted Apr 2016

Huntsville, Alabama, United States • Washington D.C., District of Columbia, United States • Fort Myers, Florida, United States +12 more locations

TERMINATEDPhase 1/2< 1 mile

Oral ONC201 in Relapsed/Refractory Multiple Myeloma

NCT02863991

This was a Phase 1/2 open-label study of ONC201 administered orally once every week in combination with dexamethasone in adults with relapsed/refractory multiple myeloma. The primary objective of this study was to evaluate the antitumor efficacy of ONC201. Note: This study was completed by predecessor company, Oncoceutics, Inc.

Multiple Myeloma

Jazz Pharmaceuticals17 participantsStarted Apr 2017

New York, New York, United States • Philadelphia, Pennsylvania, United States

Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy

Oral ONC201 in Relapsed/Refractory Multiple Myeloma

Find Trials by Condition in New York

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

Behavioral Change in the Mother-Infant Dyad: Preventing Postpartum Depression

Upright Back Posture Device Study

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

Trial of Individual Psychosocial Interventions for Cancer Patients

Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)

Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

An Observational Study to Learn More About Vericiguat Treatment Patterns and Its Safety in People With Chronic Heart Failure With Reduced Ejection Fraction in Routine Medical Care in the United States

A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT

A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer

A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)

Vestibular Implants Tested in Human Subjects

Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)